Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1964 Feb;22(1):193–203. doi: 10.1111/j.1476-5381.1964.tb01559.x

Secretory responses of extramedullary chromaffin tissue

E Muscholl, Marthe Vogt
PMCID: PMC1703904  PMID: 14126051

Abstract

When the isolated inferior mesenteric ganglion of the dog was perfused with Locke solution, the effluent fluid contained noradrenaline and adrenaline. At rest the output of noradrenaline ranged from 0.7 to 40 ng/min, and that of adrenaline from 0.7 to 25 ng/min. Electrical stimulation of the inferior splanchnic nerves did not alter the catechol amine content of the perfusate, and stimulation of the ascending mesenteric nerves caused an increase to little more than twice the resting value. When acetylcholine or dimethylphenyl-piperazinium iodide was infused into the preparation, the catechol amine content of the effluent fluid was 6- to 100-times the resting level. Two drugs with muscarinic action (pilocarpine and 3-acetoxy-1-benzyl-1-methylpyrrolidinium bromide) produced only very small increases in catechol amine release. Angiotensin, in doses ranging from 20 ng to 2 μg, inhibited release of catechol amines, and bradykinin had a weak stimulatory effect. It is suggested that the catechol amines released into the effluent fluid were derived from chromaffin tissue in the ganglion; evidence for innervation of this tissue was unobtainable, but its catechol amines were readily released by the injection of nicotinic drugs.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bülbring E. The action of adrenaline on transmission in the superior cervical ganglion. J Physiol. 1944 Jun 15;103(1):55–67. doi: 10.1113/jphysiol.1944.sp004062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CHUNGCHAROEN D., DE BURGH DALY M., SCHWEITZER A. The blood supply of the superior cervical sympathetic and the nodose ganglia in cats, dogs and rabbits. J Physiol. 1952 Dec;118(4):528–536. doi: 10.1113/jphysiol.1952.sp004814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DOLIVO M., LARRABEE M. G. Metabolism of glucose and oxygen in a mammalian sympathetic ganglion at reduced temperature and varied pH. J Neurochem. 1958 Oct;3(1):72–88. doi: 10.1111/j.1471-4159.1958.tb12611.x. [DOI] [PubMed] [Google Scholar]
  4. ECCLES R. M., LIBET B. Origin and blockade of the synaptic responses of curarized sympathetic ganglia. J Physiol. 1961 Aug;157:484–503. doi: 10.1113/jphysiol.1961.sp006738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. JONES A., GOMEZ ALONSO DE LA SIERRA B., TRENDELENBURG U. The pressor response of the spinal cat to different group of ganglion-stimulating agents. J Pharmacol Exp Ther. 1963 Mar;139:312–320. [PubMed] [Google Scholar]
  6. LINDMAR R., MUSCHOLL E. [The effect of cocaine, guanethidine, reserpine, hexamethonium, tetracaine and psicaine on noradrenalin liberation from the heart]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1961;242:214–227. [PubMed] [Google Scholar]
  7. LUND A. Release of adrenaline and noradrenaline from the suprarenal gland. Acta Pharmacol Toxicol (Copenh) 1951;7(4):309–320. doi: 10.1111/j.1600-0773.1951.tb02872.x. [DOI] [PubMed] [Google Scholar]
  8. MUSCHOLL E., VOGT M. The action of reserpine on the peripheral sympathetic system. J Physiol. 1958 Apr 3;141(1):132–155. doi: 10.1113/jphysiol.1958.sp005961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. PEACOCK J. H., SHALDON C., TYLER C., BADRICK F. E. The sympathetic postganglionic neurotransmitter substance in man. Preliminary studies. Lancet. 1962 Nov 24;2(7265):1077–1080. doi: 10.1016/s0140-6736(62)90784-5. [DOI] [PubMed] [Google Scholar]
  10. REINERT H. Role and origin of noradrenaline in the superior cervical ganglion. J Physiol. 1963 Jun;167:18–29. doi: 10.1113/jphysiol.1963.sp007130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. ROOT M. A. Certain aspects of the vasopressor action of pilocarpine. J Pharmacol Exp Ther. 1951 Feb;101(2):125–131. [PubMed] [Google Scholar]
  12. TRENDELENBURG U. The potentiation of ganglionic transmission by histamine and pilocarpine. J Physiol. 1955 Aug 29;129(2):337–351. doi: 10.1113/jphysiol.1955.sp005358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. VANOV S., VOGT M. CATECHOLAMINE-CONTAINING STRUCTURES IN THE HYPOGASTRIC NERVES OF THE DOG. J Physiol. 1963 Oct;168:939–944. doi: 10.1113/jphysiol.1963.sp007232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. VOGT M. The secretion of the denervated adrenal medulla of the cat. Br J Pharmacol Chemother. 1952 Jun;7(2):325–330. doi: 10.1111/j.1476-5381.1952.tb01329.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WEST G. B., SHEPHERD D. M., HUNTER R. B., MACGREGOR A. R. The function of the organs of Zuckerkandl. Clin Sci. 1953 Nov;12(4):317–325. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES